American Century Companies Inc Bio Atla, Inc. Transaction History

American Century Companies Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	BUY	$1.37 - $3.92 $15,759 - $45,091	11,503 Added 36.07%	43,391 $59,000
Q1 2024 May 14, 2024	BUY	$1.88 - $3.46 $59,949 - $110,332	31,888 New	31,888 $109,000
Q3 2023 Nov 13, 2023	BUY	$1.7 - $3.07 $10,897 - $19,678	6,410 Added 34.67%	24,897 $42,000
Q2 2023 Aug 14, 2023	BUY	$2.83 - $3.87 $52,318 - $71,544	18,487 New	18,487 $55,000

17.4M

500

33.5K

Ticker BCAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,304,100
Market Cap $16.7M
Description
BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and ...

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

Stay updated on American Century Companies Inc with notifications on news.